secwatch.observer — SEC 8-K summary
======================================

Issuer:     Roivant Sciences Ltd. (ROIV)
CIK:        0001635088
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0001140361-23-046010
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Roivant Sciences raises ~$200M via registered direct offering of 19.6M shares at $10.21
--------------------------------------------------------------------------------

- Sold 19,600,685 common shares at $10.21 each for aggregate gross proceeds of ~$200.1 million.
- Net proceeds to be used for investment into subsidiary Immunovant, Inc. and for working capital and general corporate purposes.
- Offering made pursuant to prospectus supplement under effective shelf registration statement (Form S-3).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1635088/000114036123046010/0001140361-23-046010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1635088/000114036123046010/ny20011553x2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-046010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer